MYOCD acts as a tumor suppressor by inhibiting stemness in non-small cell lung carcinoma (NSCLC), downregulated in lung squamous cell carcinoma and lung adenocarcinoma. Here, MYOCD is linked to non-small cell lung carcinoma.